User:ChrisMisu/Generic drug

Article body
But once the price of the reference drug product goes down, the prices of biosimilars and the generics will become adopted, forced by the payors. This will reduce the incentive for generics and biosimilars to enter the market. So instead of focusing on advertising, associations promoting generics should work to educate the developers and the regulatory agencies to try to prevent the single-source status of drugs.